Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Milestone symbols : Azn save search
Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
Published: 2024-01-08 (Crawled : 12:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 2.29%
H: 8.38%
C: 4.47%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: 0.28%
H: 0.99%
C: 0.93%
first million payment astrazeneca cancer trial milestone
Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
Published: 2023-12-19 (Crawled : 12:30) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 178.08%
H: 21.18%
C: -1.48%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: -0.5%
H: 0.99%
C: 0.43%
first payment astrazeneca cancer trial milestone
HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung Cancer
Published: 2022-03-07 (Crawled : 05:00) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: -1.8%
HCM | $18.25 7.73% 6.92% 0
|
Health Technology
|
| O: -10.68%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
orpathys star lung cancer one cancer milestone
Compugen Announces Milestone Payment from AstraZeneca Triggered by First Patient Dosed with TIGIT Bispecific Derived from COM902
Published: 2021-10-04 (Crawled : 14:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 0.5%
H: 4.17%
C: 0.83%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: 1.28%
H: 0.83%
C: 0.82%
milestone
HUTCHMED Announces First Commercial Sale of ORPATHYS® in China, Triggering a US$25 million Milestone Payment from AstraZeneca
Published: 2021-07-13 (Crawled : 07:00) - globenewswire.com
HCM | $18.25 7.73% 6.92% 0
|
Health Technology
|
| O: -0.45%
H: 2.92%
C: 2.12%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: -0.68%
H: 0.94%
C: 0.87%
china milestone commercialization
Compugen Announces First Development Milestone in License Agreement with AstraZeneca for the Development of Bispecific and Multi-specific Antibody Products
Published: 2020-12-23 (Crawled : 18:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 4.37%
H: 0.88%
C: -8.78%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: 0.78%
H: 0.02%
C: -0.69%
license antibody milestone
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M
|
Finance
RILY | $21.72 0.84% 32.09% 1.9M
|
Finance
HKIT | $1.33 30.39% 27.14% 39K
|
Technology Services
TPET | $0.3601 -4.51% 23.11% 11M
|
n/a
VRT 4 | $79.17 4.08% 19.36% 6.6M
|
Electronic Technology
PEGY | $0.0566 23.58% 15.65% 11M
|
Manufacturing
FOA 4 | $0.5144 -8.16% 15.43% 20
|
Finance and Insurance
BOF | $1.17 6.36% 14.73% 15K
|
LUCY | $0.2545 9.93% 13.94% 66K
|
n/a
TSLA | News | $144.68 1.85% 12.11% 6.9M
|
Consumer Durables
Your saved searches
Save your searches and get alerts when important news are released.